News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,121 Results
Type
Article (14173)
Company Profile (282)
Press Release (251666)
Section
Business (79491)
Career Advice (153)
Deals (13224)
Drug Delivery (35)
Drug Development (50433)
Employer Resources (31)
FDA (5711)
Job Trends (5127)
News (144361)
Policy (10028)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (910)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21632)
ALS (59)
Alzheimer's disease (820)
Antibody-drug conjugate (ADC) (82)
Approvals (5720)
Artificial intelligence (104)
Autoimmune disease (10)
Automation (5)
Bankruptcy (104)
Best Places to Work (4560)
BIOSECURE Act (5)
Biosimilars (38)
Biotechnology (232)
Bladder cancer (42)
Brain cancer (19)
Breast cancer (137)
Cancer (1236)
Cardiovascular disease (100)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (302)
Cervical cancer (6)
Clinical research (40808)
Collaboration (491)
Compensation (216)
Complete response letters (13)
COVID-19 (1031)
CRISPR (36)
C-suite (137)
Cystic fibrosis (75)
Data (1287)
Denatured (11)
Depression (28)
Diabetes (122)
Diagnostics (1290)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (76)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (77)
Earnings (29555)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48012)
Executive appointments (396)
FDA (6307)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (457)
Gene editing (86)
Generative AI (9)
Gene therapy (224)
GLP-1 (350)
Government (1074)
Grass and pollen (2)
Guidances (18)
Healthcare (6585)
Huntington's disease (21)
IgA nephropathy (19)
Immunology and inflammation (78)
Indications (18)
Infectious disease (1089)
Inflammatory bowel disease (109)
Inflation Reduction Act (8)
Influenza (17)
Intellectual property (54)
Interviews (17)
IPO (7261)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (199)
Leadership (2)
Legal (1386)
Liver cancer (30)
Lung cancer (176)
Lymphoma (81)
Machine learning (1)
Management (7)
Manufacturing (113)
MASH (46)
Medical device (2586)
Medtech (2587)
Mergers & acquisitions (6245)
Metabolic disorders (356)
Multiple sclerosis (50)
NASH (13)
Neurodegenerative disease (55)
Neuropsychiatric disorders (23)
Neuroscience (1178)
NextGen: Class of 2025 (2016)
Non-profit (852)
Northern California (1493)
Now hiring (21)
Obesity (183)
Opinion (100)
Ovarian cancer (57)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (102)
Partnered (6)
Patents (105)
Patient recruitment (64)
Peanut (35)
People (25471)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14409)
Phase II (18984)
Phase III (12002)
Pipeline (635)
Podcasts (45)
Policy (34)
Postmarket research (852)
Preclinical (6036)
Press Release (30)
Prostate cancer (51)
Psychedelics (35)
Radiopharmaceuticals (211)
Rare diseases (267)
Real estate (1414)
Recruiting (12)
Regulatory (8527)
Reports (15)
Research institute (936)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (89)
Series B (57)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1327)
Special edition (11)
Spinal muscular atrophy (116)
Sponsored (11)
Startups (1971)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (33)
United States (11780)
Vaccines (203)
Venture capitalists (28)
Webinars (7)
Weight loss (103)
Women's health (15)
Worklife (2)
Date
Today (75)
Last 7 days (324)
Last 30 days (1654)
Last 365 days (20040)
2025 (4299)
2024 (20552)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (51)
Arkansas (5)
Asia (17186)
Australia (2913)
California (3415)
Canada (1033)
China (308)
Colorado (129)
Connecticut (141)
Delaware (86)
Europe (36971)
Florida (399)
Georgia (104)
Idaho (16)
Illinois (208)
India (7)
Indiana (84)
Iowa (1)
Japan (66)
Kansas (58)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (438)
Massachusetts (2698)
Michigan (69)
Minnesota (133)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (13)
New Jersey (855)
New Mexico (12)
New York (938)
North Carolina (510)
North Dakota (4)
Northern California (1493)
Ohio (107)
Oklahoma (9)
Oregon (21)
Pennsylvania (649)
Puerto Rico (3)
Rhode Island (14)
South America (208)
South Carolina (4)
Southern California (1327)
Tennessee (25)
Texas (386)
Utah (48)
Virginia (66)
Washington D.C. (28)
Washington State (315)
Wisconsin (13)
266,121 Results for "monopar therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rosalind Franklin University’s Helix 51 Incubator Welcomes Monopar Therapeutics
Monopar’s pipeline includes clinical-stage radiopharmaceuticals targeting advanced solid tumors and late-stage ALXN1840, a treatment for Wilson Disease
January 23, 2025
·
1 min read
Business
Monopar Announces CFO Succession
Monopar Therapeutics Inc., a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, announced that after a career spanning more than 35 years, Monopar’s Chief Financial Officer, Kim R. Tsuchimoto, will be retiring.
May 24, 2024
·
4 min read
Business
Monopar and NorthStar Amend & Extend Collaboration
Monopar Therapeutics Inc., a clinical-stage radiopharma company, and NorthStar Medical Radioisotopes, LLC, a global innovator in development and commercial production of medical radioisotopes, announced an amendment and expansion to their existing collaboration.
June 11, 2024
·
6 min read
Press Releases
Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
December 6, 2024
·
5 min read
Press Releases
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
October 29, 2024
·
4 min read
Press Releases
Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
November 8, 2024
·
7 min read
Press Releases
Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
December 23, 2024
·
4 min read
Business
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
Monopar Therapeutics Inc., a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, announced first quarter 2024 financial results and summarized recent developments.
May 9, 2024
·
7 min read
BioMidwest
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
Monopar Therapeutics Inc. (Nasdaq: MNPR) today announced that it has filed a provisional patent application pertaining to the recent advancements and optimizations Monopar has achieved with its MNPR-101 radiopharmaceutical program.
April 16, 2024
·
4 min read
Press Releases
Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock
October 31, 2024
·
4 min read
1 of 26,613
Next
